Omics

How does progress in sequencing technology impact studies in cancer genomics?

Investigating biomarkers for early dementia diagnosis

New research shows how proteins, RNA, and smoking status can predict lung adenocarcinoma outcomes

How real-world data such as genomics can inform better disease forecasting

Rapid, reliable, widespread whole genome sequencing could shorten the rare disease diagnostic odyssey and improve patients’ lives

Like the progression of the disease itself, the growth of knowledge around chronic lymphocytic leukemia is slow, but steady

By uniting three medical disciplines, can we predict the effectiveness of non-small cell lung cancer treatment?

How advances in our understanding of intratumor heterogeneity (ITH) may lay a path for new clinical applications

How noninvasive proteomic biomarkers could improve liver disease diagnosis and management

The field of pan-cancer omics is taking in the full picture for viable oncology treatments